Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmirtazapine in Chronic Primary Insomnia
NCT00631657Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Nov 2009
01
Overview
A Phase 3 trial of esmirtazapine in Chronic Primary Insomnia, sponsored by Merck & Co.. Started Mar 2008; status: completed.
02
Drugs
esmirtazapine
03
Conditions
Chronic Primary Insomnia
Beyond the preview
Go deeper on NCT00631657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631657.